These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 24025545)
1. Blockade of cytidine triphosphate synthase regulates smooth muscle cell and endothelial cell proliferation differentially. Tanaka K; Sata M Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2286-7. PubMed ID: 24025545 [No Abstract] [Full Text] [Related]
2. CTP synthase 1, a smooth muscle-sensitive therapeutic target for effective vascular repair. Tang R; Cui XB; Wang JN; Chen SY Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2336-44. PubMed ID: 24008161 [TBL] [Abstract][Full Text] [Related]
3. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury. Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955 [TBL] [Abstract][Full Text] [Related]
4. Cyclopentenyl cytosine increases the phosphorylation and incorporation into dna of arabinofu-ranosyl cytosine in a myeloid leukemic cell-line. Verschuur AC; van Gennip AH; Leen R; Voûte PA; van Kuilenburg AB Adv Exp Med Biol; 2000; 486():311-7. PubMed ID: 11783507 [No Abstract] [Full Text] [Related]
5. Cyclopentenyl cytosine induces apoptosis and secondary necrosis in a T-lymphoblastic leukemic cell-line. Verschuur AC; van Gennip AH; Brinkman J; Voûte PA; van Kuilenburg AB Adv Exp Med Biol; 2000; 486():319-25. PubMed ID: 11783508 [No Abstract] [Full Text] [Related]
6. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia. Verschuur AC; Van Gennip AH; Leen R; Meinsma R; Voute PA; van Kuilenburg AB Br J Haematol; 2000 Jul; 110(1):161-9. PubMed ID: 10930994 [TBL] [Abstract][Full Text] [Related]
7. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury. Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088 [TBL] [Abstract][Full Text] [Related]
8. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition. Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709 [TBL] [Abstract][Full Text] [Related]
12. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis. Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742 [TBL] [Abstract][Full Text] [Related]
13. Cyclopentenyl cytosine (CPEC): an overview of its in vitro and in vivo activity. Schimmel KJ; Gelderblom H; Guchelaar HJ Curr Cancer Drug Targets; 2007 Aug; 7(5):504-9. PubMed ID: 17691910 [TBL] [Abstract][Full Text] [Related]
15. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells. Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388 [TBL] [Abstract][Full Text] [Related]
16. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform. Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II facilitates neointimal formation by increasing vascular smooth muscle cell migration: Involvement of APE/Ref-1-mediated overexpression of sphingosine-1-phosphate receptor 1. Lee DY; Won KJ; Lee KP; Jung SH; Baek S; Chung HW; Choi WS; Lee HM; Lee BH; Jeon BH; Kim B Toxicol Appl Pharmacol; 2018 May; 347():45-53. PubMed ID: 29609002 [TBL] [Abstract][Full Text] [Related]
18. CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase. Huang M; Wang Y; Collins M; Graves LM Leukemia; 2004 Nov; 18(11):1857-63. PubMed ID: 15385935 [TBL] [Abstract][Full Text] [Related]
19. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol. Sun L; Zhao R; Zhang L; Zhang W; He G; Yang S; Song J; Du G Biochem Pharmacol; 2016 Mar; 103():40-52. PubMed ID: 26807478 [TBL] [Abstract][Full Text] [Related]
20. Blockade of connexin 43 hemichannels reduces neointima formation after vascular injury by inhibiting proliferation and phenotypic modulation of smooth muscle cells. Song M; Yu X; Cui X; Zhu G; Zhao G; Chen J; Huang L Exp Biol Med (Maywood); 2009 Oct; 234(10):1192-200. PubMed ID: 19596827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]